Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: AIDS Care. 2019 Jul 9;32(4):438–444. doi: 10.1080/09540121.2019.1640854

Table 3.

Factors associated with not being in the appropriate grade-for-age, children living with HIV (CLWH)

Factor n/N (%) Unadjusted OR (95% CI) P Adjusted OR (95% CI)* P
Age at ART initiation
 ≥6 months 99/177 (55.9) 1.91 (1.31, 2.78) 0.0007 1.74 (1.05, 2.88) 0.032
 <6 months 121/303 (39.9) 1.0 1.0
Age in years 1.00 (0.87, 1.14) 0.98
Sex
 Male 121/219 (55.3) 2.02 (1.40, 2.91) 0.0002 1.67 (1.08, 2.57) 0.021
 Female 99/261 (37.9) 1.0 1.0
Site
 ESRU 136/235 (57.9) 2.63 (1.82, 3.81) <0.0001 1.96 (0.99, 3.87) 0.054
 PHRU 84/245 (34.3) 1.0 1.0
Biological mother is primary caregiver
 No 32/73 (43.8) 0.91 (0.55, 1.50) 0.71 - -
 Yes 188/407 (46.2) 1.0
Biological mother is alive
 No 202/447 (45.2) 1.29 (0.62, 2.68) 0.49 - -
 Yes 16/31 (51.6) 1.0
Biological father is alive
 No 176/400 (44.0) 1.57 (0.93, 2.64) 0.09 1.57 (0.85, 2.90) 0.15
 Yes 37/67 (55.2) 1.0
Highest caregiver grade completed
 No school / did not finish high school 125/254 (49.2) 1.34 (0.93, 1.92) 0.12 - -
 Completed high school 95/226 (42.0) 1.0
Child lives in a house
 No 142/323 (44.0) 1.26 (0.86, 1.85) 0.24 - -
 Yes 78/157 (49.7) 1.0
Has a foreign born parent
 Yes 177/391 (45.3) 1.13 (0.71, 1.79) 0.60 - -
 No 43/89 (48.3) 1.0
Current plasma HIV RNA (copies/ml)
 Not suppressed >40 26/48 (54.2) 1.45 (0.79, 2.63) 0.23 - -
 Suppressed <40 193/429 (45.0) 1.0
Current CD4 percentage (%) 1.00 (0.97, 1.03) 0.99 - -
Current ART regimen
 EFV-based 103/178 (57.9) 2.15 (1.47, 3.15) <0.0001 0.86 (0.44, 1.68) 0.67
 LPV/r-based 113/290 (39.0) 1.0 1.0 0.75
 Other 4/12 (33.3) 0.78 (0.23, 2.66) 0.70 0.78 (0.17, 3.51)
Child has been told his/her HIV status
 No 120/222 (54.1) 1.82 (1.27, 2.63) 0.001 1.87 (1.18, 2.95) 0.008
 Yes 100/255 (39.2) 1.0 1.0
 Don’t know 0/3 (0.0) - -
Pre-treatment HIV RNA (copies/ml)
 <100,000 20/35 (57.1) 1.0 1.0
 100,000–340,000 23/65 (35.4) 0.41 (0.18, 0.95) 0.04 0.40 (0.16, 0.99) 0.047
 340,000–750,000 33/68 (48.5) 0.71 (0.31, 1.61) 0.41 0.92 (0.37, 2.27) 0.85
 ≥750,000 113/245 (46.1) 0.64 (0.31, 1.31) 0.22 0.73 (0.33, 1.59) 0.42
Pre-treatment CD4 percentage (%) 0.96 (0.95, 0.98) <0.0001 0.97 (0.96, 1.00) 0.054
*

The adjusted model includes all variables with p<0.10 in unadjusted analysis.